Heather Pugmire
Obstetrics & Gynecology · Blackfoot, IDNPI 1225292220
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. Pfizer accounts for 72.8% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $2,156 and has fallen 98.7% since, to $27 in 2025.
Across 47 payments — averaging $61.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$2K
- AbbVie$129
- Astellas Pharma US Inc$108
- Johnson & Johnson$73
- Hologic Sales And Service, LLC$69
- Coloplast$69
- plus $335 from 12 others
Across 256 payments — averaging $10,184 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$1.7M
- Bavarian Nordic A/s$719K
- AbbVie$97K
- Modernatx, Inc.$45K
What the payments were for
- Travel & lodging$1,40549%
- Food & beverage$1,45050%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 7 | $2,091 |
| AbbVie(2 entities) | 8 | $129 |
| Astellas Pharma US Inc | 5 | $108 |
| Johnson & Johnson | 2 | $73 |
| Hologic Sales And Service, LLC | 4 | $69 |
| Coloplast | 3 | $69 |
| Bayer | 3 | $48 |
| Exeltis, USA Inc. | 3 | $47 |
| Myriad Women's Health, Inc. | 1 | $33 |
| AMAG Pharmaceuticals, Inc. | 1 | $31 |
| Therapeuticsmd, Inc. | 2 | $31 |
| Merck | 2 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Covidien LP | 1 | $26 |
| Shield Therapeutics Inc | 1 | $22 |
| Mayne Pharma Commercial LLC | 1 | $17 |
| Agile Therapeutics, Inc. | 1 | $13 |
| Avanos Medical | 1 | $11 |
How this compares
$2,873 in reported general payments places this provider in the 75th percentile of 166 obstetrics & gynecology providers in Idaho.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 43 | $3,059 |
| Oxybutynin Chloride ErOxybutynin Chloride | 15 | $1,211 |
| YuvafemEstradiol | 12 | $613 |
| Paroxetine Hcl | 11 | $108 |
| Alendronate Sodium | 15 | $93 |
| Levothyroxine Sodium | 20 | $59 |
| Atorvastatin Calcium | 12 | $45 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $44 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Blackfoot
- Ty EricksonIdaho Falls$286K
- Kim CoxPocatello$24K
- Kelly SiudzinskiMeridian$22K
- Michael CannonTwin Falls$18K
- Jeffrey BakerIdaho Falls$18K
- Glenn LeavittIdaho Falls$17K
- Guillermo Guzman TrevinoNampa$15K
- John MercerNampa$13K
- Jason ParkinsonBurley$13K
- Jacqueline MaybachBoise$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.